DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2019366): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
| label / it | label / it | ||
SVILUPPO DI UNA PIATTAFORMA PER L'IDENTIFICAZIONE DEL MUTANOMA E LA VACCINAZIONE PERSONALIZZATA IN PAZIENTI AFFETTI DA TUMORE - | SVILUPPO DI UNA PIATTAFORMA PER L'IDENTIFICAZIONE DEL MUTANOMA E LA VACCINAZIONE PERSONALIZZATA IN PAZIENTI AFFETTI DA TUMORE - PRECIVAX | ||
| label / en | label / en | ||
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX | ||
Revision as of 04:48, 2 November 2020
Project Q2019366 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX |
Project Q2019366 in Italy |
Statements
986,675.87 Euro
0 references
1,329,656.71 Euro
0 references
74.21 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
0 references
BIOTECNOLOGIE (Italian)
0 references
BIOTECHNOLOGY (English)
0 references
Identifiers
B88I17000390008
0 references